Company intelligence

Company pipelines

Drug pipeline tracking for the companies behind the experimental drugs we profile. Each page combines live registry statistics from ClinicalTrials.gov with tracked drug profiles and sourced milestones.

CompanyListingActive trials (lead sponsor)Active Phase 3Tracked drugs
Amgen
Thousand Oaks, California, United States
Nasdaq: AMGN10450Olpasiran
Eli Lilly and Company
Indianapolis, Indiana, United States
NYSE: LLY24194Retatrutide, Orforglipron, Lepodisiran, Muvalaplin
Merck & Co.
Rahway, New Jersey, United States
NYSE: MRK228107Enlicitide, Sacituzumab tirumotecan
NewAmsterdam Pharma
Naarden, the Netherlands
Nasdaq: NAMS63Obicetrapib
Novartis
Basel, Switzerland
NYSE: NVS36289Pelacarsen
Novo Nordisk
Bagsværd, Denmark
NYSE: NVO14650CagriSema
Silence Therapeutics
London, United Kingdom
Nasdaq: SLN10Zerlasiran

Active means recruiting, not yet recruiting, active (not recruiting), or enrolling by invitation on ClinicalTrials.gov. Phase 3 counts include combined Phase 2/3 trials. Counts reflect trials where the company is the registered lead sponsor.